The value of assessing the risk of CNS relapse in lymphoma and providing CNS-directed prophylaxis for at-risk patients remains underappreciated. According to a ‘How I Treat’ article in Blood, there is also no consensus around optimal dose, timing or route of prophylactic therapy. Dr Chan Cheah, from the Sir Charles Gairdner Hospital in WA, told ...
CNS relapse a neglected area of lymphoma management
By Mardi Chapman
5 Sep 2017